In this executive summary, we describe the benefits of controlled release, look at how to determine whether a drug is suitable for controlled release, review the application of PBPK modelling in controlled release formulation development and discuss how modified release products can be developed to deliver optimal patient outcomes.
By submitting this contact form, you accept that you may receive direct communication from the sponsor(s).
Developed by Endpoints Studio © 2022
Is your product a candidate for controlled release? Find out how it can optimize patient outcomes
Complete the form below to access the executive summary:
LEARN MORE ABOUT: